Showing results (3971-3980 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|December 23, 2011
Oxidative stress and mitochondrial impairment after treatment with anti-HIV drugs: clinical implicationsAna Blas-Garcia, Nadezda Apostolova, Juan V EspluguesCurrent Pharmaceutical Design|January 31, 2012
In vivo pharmacokinetics, immunogenicity and mechanism of PEGylated antitumor polypeptideZhendong Liu, Weiguang Li, Han-Mei Xu, et al.Current Pharmaceutical Design|January 31, 2012
New developments in treatment after lung transplantationChristian Benden, Lara Danziger-Isakov, Albert FaroCurrent Pharmaceutical Design|January 31, 2012
Role of the renin-angiotensin-aldosterone system in the pathogenesis of atherosclerosisAlessandro Durante, Giovanni Peretto, Alessandra Laricchia, et al.Current Pharmaceutical Design|January 31, 2012
Combinations of renin-angiotensin-aldosterone system antagonists: true advantages?Franco Veglio, Elisabetta Puglisi, Alberto Milan, et al.Current Pharmaceutical Design|January 31, 2012
RAAS inhibition and renal protectionGiovanna Leoncini, Leoncini Giovanna, Francesca Viazzi, et al.Current Pharmaceutical Design|January 31, 2012
Effects of ACE-inhibitors and angiotensin receptor blockers on inflammationD Di Raimondo, A Tuttolomondo, C Buttà, et al.Current Pharmaceutical Design|January 4, 2012
From small to big molecules: how do we prevent and delay the progression of age-related neurodegeneration?Yuen-Shan Ho, David Chun-Hei Poon, Tin-Fung Chan, et al.Current Pharmaceutical Design|January 4, 2012
High fat meal increase of IL-17 is prevented by ingestion of fruit juice drink in healthy overweight subjectsIlaria Peluso, Anna Raguzzini, Debora V Villano, et al.Current Pharmaceutical Design|January 4, 2012
Neuroprotective effects of lutein in the retinaYoko Ozawa, Mariko Sasaki, Noriko Takahashi, et al.Pageof 1,008